CDG therapies: from bench to bedside

Detalhes bibliográficos
Autor(a) principal: Brasil, Sandra
Data de Publicação: 2018
Outros Autores: Pascoal, Carlota, Francisco, Rita, Marques-da-Silva, Dorinda, Andreotti, Giuseppina, Videira, Paula A., Morava, Eva, Jaeken, Jaak, Dos Reis Ferreira, Vanessa
Tipo de documento: Outros
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.3390/ijms19051304
Resumo: SFRH/BD/124326/2016
id RCAP_ac28a317b741b2f9dc29fc72690acbb7
oai_identifier_str oai:run.unl.pt:10362/61645
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling CDG therapies: from bench to bedsideAnimal modelsBiomarkersClinical trialsCongenital disorders of glycosylation (CDG)DiagnosisDietary supplementationGalactoseMannosePharmacological chaperonesTherapyCatalysisMolecular BiologySpectroscopyComputer Science ApplicationsPhysical and Theoretical ChemistryOrganic ChemistryInorganic ChemistrySFRH/BD/124326/2016Congenital disorders of glycosylation (CDG) are a group of genetic disorders that affect protein and lipid glycosylation and glycosylphosphatidylinositol synthesis. More than 100 different disorders have been reported and the number is rapidly increasing. Since glycosylation is an essential post-translational process, patients present a large range of symptoms and variable phenotypes, from very mild to extremely severe. Only for few CDG, potentially curative therapies are being used, including dietary supplementation (e.g., galactose for PGM1-CDG, fucose for SLC35C1-CDG, Mn2+ for TMEM165-CDG or mannose for MPI-CDG) and organ transplantation (e.g., liver for MPI-CDG and heart for DOLK-CDG). However, for the majority of patients, only symptomatic and preventive treatments are in use. This constitutes a burden for patients, care-givers and ultimately the healthcare system. Innovative diagnostic approaches, in vitro and in vivo models and novel biomarkers have been developed that can lead to novel therapeutic avenues aiming to ameliorate the patients’ symptoms and lives. This review summarizes the advances in therapeutic approaches for CDG.DCV - Departamento de Ciências da VidaUCIBIO - Applied Molecular Biosciences UnitRUNBrasil, SandraPascoal, CarlotaFrancisco, RitaMarques-da-Silva, DorindaAndreotti, GiuseppinaVideira, Paula A.Morava, EvaJaeken, JaakDos Reis Ferreira, Vanessa2019-02-25T23:17:19Z2018-05-012018-05-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/otherapplication/pdfhttps://doi.org/10.3390/ijms19051304eng1661-6596PURE: 4156810http://www.scopus.com/inward/record.url?scp=85046299553&partnerID=8YFLogxKhttps://doi.org/10.3390/ijms19051304info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-05-22T17:37:25Zoai:run.unl.pt:10362/61645Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-05-22T17:37:25Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv CDG therapies: from bench to bedside
title CDG therapies: from bench to bedside
spellingShingle CDG therapies: from bench to bedside
Brasil, Sandra
Animal models
Biomarkers
Clinical trials
Congenital disorders of glycosylation (CDG)
Diagnosis
Dietary supplementation
Galactose
Mannose
Pharmacological chaperones
Therapy
Catalysis
Molecular Biology
Spectroscopy
Computer Science Applications
Physical and Theoretical Chemistry
Organic Chemistry
Inorganic Chemistry
title_short CDG therapies: from bench to bedside
title_full CDG therapies: from bench to bedside
title_fullStr CDG therapies: from bench to bedside
title_full_unstemmed CDG therapies: from bench to bedside
title_sort CDG therapies: from bench to bedside
author Brasil, Sandra
author_facet Brasil, Sandra
Pascoal, Carlota
Francisco, Rita
Marques-da-Silva, Dorinda
Andreotti, Giuseppina
Videira, Paula A.
Morava, Eva
Jaeken, Jaak
Dos Reis Ferreira, Vanessa
author_role author
author2 Pascoal, Carlota
Francisco, Rita
Marques-da-Silva, Dorinda
Andreotti, Giuseppina
Videira, Paula A.
Morava, Eva
Jaeken, Jaak
Dos Reis Ferreira, Vanessa
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv DCV - Departamento de Ciências da Vida
UCIBIO - Applied Molecular Biosciences Unit
RUN
dc.contributor.author.fl_str_mv Brasil, Sandra
Pascoal, Carlota
Francisco, Rita
Marques-da-Silva, Dorinda
Andreotti, Giuseppina
Videira, Paula A.
Morava, Eva
Jaeken, Jaak
Dos Reis Ferreira, Vanessa
dc.subject.por.fl_str_mv Animal models
Biomarkers
Clinical trials
Congenital disorders of glycosylation (CDG)
Diagnosis
Dietary supplementation
Galactose
Mannose
Pharmacological chaperones
Therapy
Catalysis
Molecular Biology
Spectroscopy
Computer Science Applications
Physical and Theoretical Chemistry
Organic Chemistry
Inorganic Chemistry
topic Animal models
Biomarkers
Clinical trials
Congenital disorders of glycosylation (CDG)
Diagnosis
Dietary supplementation
Galactose
Mannose
Pharmacological chaperones
Therapy
Catalysis
Molecular Biology
Spectroscopy
Computer Science Applications
Physical and Theoretical Chemistry
Organic Chemistry
Inorganic Chemistry
description SFRH/BD/124326/2016
publishDate 2018
dc.date.none.fl_str_mv 2018-05-01
2018-05-01T00:00:00Z
2019-02-25T23:17:19Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/other
format other
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.3390/ijms19051304
url https://doi.org/10.3390/ijms19051304
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1661-6596
PURE: 4156810
http://www.scopus.com/inward/record.url?scp=85046299553&partnerID=8YFLogxK
https://doi.org/10.3390/ijms19051304
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv mluisa.alvim@gmail.com
_version_ 1817545676892930048